Teva canada welcomes public drug plan reimbursement by alberta, saskatchewan, quÉbec, veteran affairs canada and the non-insured health benefits program for patients prescribed ajovy® (fremanezumab) for the preventive treatment of migraine in adults

MontrÉal--(business wire)--teva canada welcomes public formulary and program coverage making ajovy® (fremanezumab) accessible to more migraine patients across canada
TEVA Ratings Summary
TEVA Quant Ranking